Product Information
ESTRADIOL 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0796 per EA under NDC 00555088704. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 22, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555088704
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
Generic (ANDA)
FDA Application
ANDA040197FDA Approved
10/22/1997
TE Code
AB
On Market Since
10/28/1997
Pharmacological Classes
Price Statistics
The NADAC for ESTRADIOL 2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0796 per EA |
|---|---|
| All-time high | $0.1717 (Sep 16, 2015) |
| All-time low | $0.0712 (Nov 20, 2024) |
| 52-week high | $0.0901 |
| 52-week low | $0.0796 |
| Median price | $0.1284 |
| Average price | $0.1250 |
| Largest weekly change | +61.1% (Jul 22, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESTRADIOL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESTRADIOL 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0796 per EA (NDC 00555088704), effective Sep 30, 2026.
How has the price of ESTRADIOL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESTRADIOL 2 MG TABLET has declined 22.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ESTRADIOL 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ESTRADIOL 2 MG TABLET has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.1717 (Sep 16, 2015), with a median of $0.1284 per EA.
Are there cheaper alternatives to ESTRADIOL 2 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESTRADIOL 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESTRADIOL 2 MG TABLET?
ESTRADIOL 2 MG TABLET (NDC 00555088704) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.